ACTRN12610000643077招募中不适用
Evaluation of Silymarin in treatment of anti tuberculosis drug induced hepatitis in patients newly diagnosed with tuberculosis.
ational Institute of Tuberculosis and Lung Disease (NRITLD)0 个研究点目标入组 60 人开始时间: 2010年8月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •New cases of tuberculosis
排除标准
- •1. Infection with Human Immune deficiency virus 2. Infection with hepatitis B virus 3. Infection with hepatitis c virus 4.pregnancy 5. Breast feeding
研究者
相似试验
已完成
不适用
Effect of silymarin in prevention of adverse effects of anti tuberculosis drugs.TuberculosisACTRN12610000621011ational Institute of Tuberculosis and Lung Disease (NRITLD)60
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60